AptarGroup target price raised to $160 from $155
ATR•Raymond James raised its target price for AptarGroup to $160 from $155.
Related News
Actuate Therapeutics receives US patent allowance for elraglusib oral tablets
ACTU•
Infleqtion Inc: B. Riley cuts target price to $17 from $23
INFQ•
NPK International Inc.: B. Riley cuts target price to $15 from $21
NPKI•
GameSquare publishes financial calendar update
GAME•
Carlyle provides $225 million financing to Kingbee for fleet expansion
CG•